|
LIG3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.56440000004454E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.193100E-04 |
| Normal-vs-Stage2 |
5.024200E-03 |
| Normal-vs-Stage3 |
8.3823999996735E-07 |
| Normal-vs-Stage4 |
6.15609999999878E-05 |
| Stage1-vs-Stage2 |
9.284000E-01 |
| Stage1-vs-Stage3 |
6.884100E-02 |
| Stage1-vs-Stage4 |
3.368400E-01 |
| Stage2-vs-Stage3 |
2.704600E-01 |
| Stage2-vs-Stage4 |
5.573600E-01 |
| Stage3-vs-Stage4 |
5.829000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.03229999995447E-06 |
| Normal-vs-AfricanAmerican |
9.780100E-04 |
| Normal-vs-Asian |
4.607000E-01 |
| Caucasian-vs-AfricanAmerican |
9.005400E-01 |
| Caucasian-vs-Asian |
2.220400E-02 |
| AfricanAmerican-vs-Asian |
4.514200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.86939999935865E-08 |
| Normal-vs-Female |
3.203000E-03 |
| Male-vs-Female |
1.220760E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.198300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.355210E-04 |
| Normal-vs-Age(61-80Yrs) |
1.87029999998423E-06 |
| Normal-vs-Age(81-100Yrs) |
3.159800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.506800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.982600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.943400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.060600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.089000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.017200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.458200E-01 |
| Normal-vs-Grade 2 |
1.240740E-04 |
| Normal-vs-Grade 3 |
4.57640000006698E-07 |
| Normal-vs-Grade 4 |
6.22209999999734E-05 |
| Grade 1-vs-Grade 2 |
3.731800E-01 |
| Grade 1-vs-Grade 3 |
1.101630E-01 |
| Grade 1-vs-Grade 4 |
1.505960E-01 |
| Grade 2-vs-Grade 3 |
7.913900E-02 |
| Grade 2-vs-Grade 4 |
2.482000E-01 |
| Grade 3-vs-Grade 4 |
9.297600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.641200E-04 |
| Normal-vs-ccB subtype |
2.06869999999082E-05 |
| ccA subtype-vs-ccB subtype |
1.686240E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.49969999999156E-05 |
| Normal-vs-N1 |
9.125600E-02 |
| N0-vs-N1 |
5.969600E-01 |
|
|
